Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2021 May 5:2021.05.02.21256495.
doi: 10.1101/2021.05.02.21256495.

Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis

Affiliations

Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis

Jay J Xu et al. medRxiv. .

Update in

  • This article has been published with doi: 10.3390/app11167403

Abstract

Males are at higher risk relative to females of severe outcomes following COVID-19 infection. Focusing on COVID-19-attributable mortality in the United States (U.S.), we quantify and contrast years of potential life lost (YPLL) attributable to COVID-19 by sex based on data from the U.S. National Center for Health Statistics as of 31 March 2021, specifically by contrasting male and female percentages of total YPLL with their respective percent population shares and calculating age-adjusted male-to-female YPLL rate ratios both nationally and for each of the 50 states and the District of Columbia. Using YPLL before age 75 to anchor comparisons between males and females and a novel Monte Carlo simulation procedure to perform estimation and uncertainty quantification, our results reveal a near-universal pattern across states of higher COVID-19-attributable YPLL among males compared to females. Furthermore, the disproportionately high COVID-19 mortality burden among males is generally more pronounced when measuring mortality in terms of YPLL compared to age-irrespective death counts, reflecting dual phenomena of males dying from COVID-19 at higher rates and at systematically younger ages relative to females. The U.S. COVID-19 epidemic also offers lessons underscoring the importance of a public health environment that recognizes sex-specific needs as well as different patterns in risk factors, health behaviors, and responses to interventions between men and women. Public health strategies incorporating focused efforts to increase COVID-19 vaccinations among men are particularly urged.

Keywords: COVID-19; Monte Carlo simulation; SARS-CoV-2; United States; coronavirus; epidemiology; public health; sex disparities; vaccine hesitancy; years of potential life lost.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Conservative 95% interval estimates of the percentage of total COVID-19-attributable YPLL before age 75, the percentage of total COVID-19 deaths, and the percent population shares for males in the U.S. and in each of the 50 states and D.C. with respect to cumulative COVID-19 deaths according to data from the National Center for Health Statistics as of 31 March 2021.
Figure 2.
Figure 2.
Conservative 95% interval estimates of the percentage of total COVID-19-attributable YPLL before age 75, the percentage of total COVID-19 deaths, and the percent population shares for females in the U.S. and in each of the 50 states and D.C. with respect to cumulative COVID-19 deaths according to data from the National Center for Health Statistics as of 31 March 2021.
Figure 3.
Figure 3.
Conservative 95% interval estimates of the age-adjusted male-to-female YPLL and mortality RR’s in the U.S. and in each of the 50 states and D.C. with respect to cumulative COVID-19 deaths according to data from the National Center for Health Statistics as of 31 March 2021. States are ordered from top to bottom in descending order of the signed difference between the lower limit of the YPLL RR interval and the upper limit of the mortality RR interval.

Similar articles

References

    1. Cevik M.; Kuppalli K.; Kindrachuk J.; Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 2020, 371. - PubMed
    1. Cucinotta D.; Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio Medica 2020, 91, 157–160. - PMC - PubMed
    1. Rabin R.C. First Patient With Wuhan Coronavirus Is Identified in the U.S., Accessed 31 March 2021. https://www.nytimes.com/2020/01/21/health/cdc-coronavirus.html.
    1. Holshue M.L.; DeBolt C.; Lindquist S.; Lofy K.H.; Wiesman J.; Bruce H.; Spitters C.; Ericson K.; Wilkerson S.; Tural A.; Diaz G.; Cohn A.; Fox L.; Patel A.; Gerber S.I.; Kim L.; Tong S.; Lu X.; Lindstrom S.; Pallansch M.A.; Weldon W.C.; Biggs H.M.; Uyeki T.M.; Pillai S.K. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine 2020, 382, 929–936. - PMC - PubMed
    1. Elmore J.G.; Wang P.C.; Kerr K.F.; Schriger D.L.; Morrison D.E.; Brookmeyer R.S.; Pfeffer M.A.; Payne T.H.; Currier J.S. Excess Patient Visits for Cough and Pulmonary Disease at a Large US Health System in the Months Prior to the COVID-19 Pandemic: Time-Series Analysis. Journal of Medical Internet Research 2020, 22, e21562. - PMC - PubMed

Publication types

LinkOut - more resources